Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Sharon Mates. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Sharon Mates zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ITCI / Intra-Cellular Therapies, Inc. | Chairman and CEO, Director | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Sharon Mates. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Sharon Mates ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
D - Sale to Issuer | -190 000 | 0 | -100,00 | 132,00 | -25 080 000 | ||
| 2025-04-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
D - Sale to Issuer | -945 235 | 0 | -100,00 | 132,00 | -124 771 020 | ||
| 2025-03-31 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | 190 000 | 190 000 | |||||
| 2025-03-31 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | -190 000 | 945 235 | -16,74 | ||||
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | -10 129 | 1 135 235 | -0,88 | 131,24 | -1 329 330 | 148 988 241 | |
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 566 | 1 145 364 | 1,83 | ||||
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | -19 848 | 1 124 798 | -1,73 | 131,19 | -2 603 859 | 147 562 250 | |
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 712 | 1 144 646 | 3,69 | ||||
| 2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | -16 978 | 1 103 934 | -1,51 | 128,20 | -2 176 580 | 141 524 339 | |
| 2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 969 | 1 120 912 | 3,22 | ||||
| 2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | -15 233 | 1 085 943 | -1,38 | 127,00 | -1 934 591 | 137 914 761 | |
| 2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 30 847 | 1 101 176 | 2,88 | ||||
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 534 | 1 070 329 | -0,14 | 84,69 | -129 914 | 90 645 842 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -50 163 | 1 071 863 | -4,47 | 84,06 | -4 216 928 | 90 105 627 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 51 697 | 1 122 026 | 4,83 | 12,73 | 658 103 | 14 283 391 | |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -23 333 | 1 070 329 | -2,13 | 86,00 | -2 006 750 | 92 053 432 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -27 667 | 1 093 662 | -2,47 | 85,62 | -2 368 909 | 93 641 746 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 51 000 | 1 121 329 | 4,76 | 12,73 | 649 230 | 14 274 518 | |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -6 193 | 1 070 329 | -0,58 | 73,32 | -454 091 | 78 479 947 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -28 203 | 1 076 522 | -2,55 | 72,73 | -2 051 261 | 78 297 598 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 396 | 1 104 725 | 3,21 | 12,73 | 437 861 | 14 063 149 | |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -5 772 | 1 070 329 | -0,54 | 73,25 | -422 771 | 78 396 355 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -29 832 | 1 076 101 | -2,70 | 72,44 | -2 161 114 | 77 955 770 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 35 604 | 1 105 933 | 3,33 | 12,73 | 453 239 | 14 078 527 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -240 | 1 070 329 | -0,02 | 73,70 | -17 688 | 78 883 247 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -32 459 | 1 070 569 | -2,94 | 72,74 | -2 361 113 | 77 874 688 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 32 699 | 1 103 028 | 3,06 | 17,57 | 574 521 | 19 380 202 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -16 856 | 1 070 329 | -1,55 | 73,93 | -1 246 191 | 79 131 135 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -23 657 | 1 087 185 | -2,13 | 73,33 | -1 734 865 | 79 727 734 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 513 | 1 110 842 | 3,79 | 17,57 | 711 813 | 19 517 494 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -22 713 | 1 070 329 | -2,08 | 74,59 | -1 694 229 | 79 838 944 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 713 | 1 093 042 | 2,12 | 17,57 | 399 067 | 19 204 748 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -28 680 | 1 070 329 | -2,61 | 74,46 | -2 135 435 | 79 693 807 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 28 680 | 1 099 009 | 2,68 | 17,57 | 503 908 | 19 309 588 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -4 369 | 1 070 329 | -0,41 | 75,47 | -329 727 | 80 777 409 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -35 011 | 1 074 698 | -3,15 | 74,58 | -2 611 075 | 80 149 580 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 39 380 | 1 109 709 | 3,68 | 17,57 | 691 907 | 19 497 587 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 900 | 1 070 329 | -0,18 | 77,98 | -148 163 | 83 464 791 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -2 682 | 1 072 229 | -0,25 | 77,21 | -207 088 | 82 790 983 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -4 297 | 1 074 911 | -0,40 | 76,20 | -327 432 | 81 908 326 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -44 134 | 1 079 208 | -3,93 | 75,40 | -3 327 818 | 81 375 089 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 53 013 | 1 123 342 | 4,95 | 17,57 | 931 438 | 19 737 119 | |
| 2024-04-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 382 | 1 070 329 | 1,07 | 17,57 | 199 982 | 18 805 681 | |
| 2024-04-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 8 638 | 1 058 947 | 0,82 | 16,86 | 145 637 | 17 853 846 | |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -306 | 1 050 309 | -0,03 | 67,33 | -20 603 | 70 717 305 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 590 | 1 050 615 | -0,15 | 66,81 | -106 228 | 70 191 588 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -4 128 | 1 052 205 | -0,39 | 65,90 | -272 035 | 69 340 310 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -14 541 | 1 056 333 | -1,36 | 64,80 | -942 257 | 68 450 378 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 565 | 1 070 874 | 1,96 | ||||
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -8 754 | 1 050 309 | -0,83 | 66,93 | -585 905 | 70 297 181 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -31 958 | 1 059 063 | -2,93 | 66,38 | -2 121 372 | 70 300 602 |
| 2024-03-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 712 | 1 091 021 | 3,88 | ||||
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -12 462 | 1 050 309 | -1,17 | 70,11 | -873 711 | 73 637 164 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -9 528 | 1 062 771 | -0,89 | 69,45 | -661 720 | 73 809 446 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -600 | 1 072 299 | -0,06 | 68,39 | -41 034 | 73 334 529 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 590 | 1 072 899 | 2,15 | ||||
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -17 450 | 1 050 309 | -1,63 | 67,42 | -1 176 479 | 70 811 833 |
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -16 435 | 1 067 759 | -1,52 | 66,70 | -1 096 214 | 71 219 525 |
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 33 885 | 1 084 194 | 3,23 | ||||
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -320 | 1 050 309 | -0,03 | 66,25 | -21 200 | 69 582 971 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -67 597 | 1 050 629 | -6,05 | 65,19 | -4 406 648 | 68 490 505 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 67 917 | 1 118 226 | 6,47 | 16,86 | 1 145 081 | 18 853 290 | |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -17 451 | 1 050 309 | -1,63 | 66,66 | -1 163 284 | 70 013 598 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -30 633 | 1 067 760 | -2,79 | 66,00 | -2 021 778 | 70 472 160 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 48 084 | 1 098 393 | 4,58 | 16,86 | 810 696 | 18 518 906 | |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -5 882 | 1 050 309 | -0,56 | 67,76 | -398 564 | 71 168 938 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -65 979 | 1 056 191 | -5,88 | 67,25 | -4 437 088 | 71 028 845 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -3 500 | 1 122 170 | -0,31 | 66,38 | -232 330 | 74 489 645 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 75 361 | 1 125 670 | 7,18 | 16,86 | 1 270 586 | 18 978 796 | |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -44 413 | 1 050 309 | -4,06 | 54,17 | -2 405 852 | 56 895 239 |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -28 119 | 1 094 722 | -2,50 | 53,96 | -1 517 301 | 59 071 199 |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -27 468 | 1 122 841 | -2,39 | 53,55 | -1 470 911 | 60 128 136 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 000 | 1 150 309 | 1,77 | 3,26 | 65 200 | 3 750 007 | |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 412 | 1 130 309 | -0,12 | 44,08 | -62 241 | 49 824 021 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -19 153 | 1 131 721 | -1,66 | 45,06 | -863 034 | 50 995 348 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 565 | 1 150 874 | 1,82 | ||||
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -6 805 | 1 130 309 | -0,60 | 42,51 | -289 281 | 48 049 436 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -34 965 | 1 137 114 | -2,98 | 43,28 | -1 513 285 | 49 214 294 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 41 770 | 1 172 079 | 3,70 | ||||
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 30 000 | 1 130 309 | 2,73 | 3,26 | 97 800 | 3 684 807 | |
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -22 590 | 1 100 309 | -2,01 | 47,03 | -1 062 408 | 51 747 532 |
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 590 | 1 122 899 | 2,05 | ||||
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -251 | 1 100 309 | -0,02 | 49,60 | -12 450 | 54 575 326 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -2 502 | 1 100 560 | -0,23 | 48,70 | -121 847 | 53 597 272 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -2 200 | 1 103 062 | -0,20 | 47,35 | -104 170 | 52 229 986 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -22 895 | 1 105 262 | -2,03 | 46,54 | -1 065 533 | 51 438 893 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 848 | 1 128 157 | 2,53 | ||||
| 2022-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -33 083 | 1 100 309 | -2,92 | 55,00 | -1 819 565 | 60 516 995 |
| 2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 61 696 | 61 696 | |||||
| 2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 50 167 | 50 167 | |||||
| 2022-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -38 925 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 38 925 | 1 133 392 | 3,56 | 2,84 | 110 547 | 3 218 833 | |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -100 | 1 094 467 | -0,01 | 50,92 | -5 092 | 55 730 260 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -11 240 | 1 094 567 | -1,02 | 51,61 | -580 096 | 56 490 603 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -11 249 | 1 105 807 | -1,01 | 52,35 | -588 885 | 57 888 996 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -22 589 | 45 180 | -33,33 | ||||
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 589 | 1 117 056 | 2,06 | ||||
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -12 667 | 1 094 467 | -1,14 | 54,98 | -696 432 | 60 173 796 |
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -15 180 | 1 107 134 | -1,35 | 55,73 | -845 981 | 61 700 578 |
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -27 847 | 27 848 | -50,00 | ||||
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 847 | 1 122 314 | 2,54 | ||||
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -8 954 | 1 094 467 | -0,81 | 40,10 | -359 055 | 43 888 127 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -27 138 | 1 103 421 | -2,40 | 40,80 | -1 107 230 | 45 019 577 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -5 804 | 1 130 559 | -0,51 | 41,72 | -242 143 | 47 166 921 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -41 896 | 0 | -100,00 | ||||
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 896 | 1 136 363 | 3,83 | ||||
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -8 192 | 1 094 467 | -0,74 | 40,00 | -327 680 | 43 778 680 |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -1 075 | 38 925 | -2,69 | ||||
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 1 075 | 1 102 659 | 0,10 | 2,84 | 3 053 | 3 131 552 | |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -40 392 | 1 101 584 | -3,54 | 40,00 | -1 615 680 | 44 063 360 |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 416 | 1 141 976 | -0,12 | 40,00 | -56 640 | 45 679 040 |
| 2021-08-24 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -10 000 | 40 000 | -20,00 | ||||
| 2021-08-24 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 000 | 1 143 392 | 0,88 | 2,84 | 28 400 | 3 247 233 | |
| 2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 67 769 | 67 769 | |||||
| 2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 53 471 | 53 471 | |||||
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -3 100 | 1 133 392 | -0,27 | 38,91 | -120 621 | 44 100 283 |
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -24 747 | 1 136 492 | -2,13 | 39,27 | -971 815 | 44 630 041 |
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -27 847 | 55 695 | -33,33 | ||||
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 847 | 1 161 239 | 2,46 | ||||
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -4 585 | 1 133 392 | -0,40 | 31,64 | -145 069 | 35 860 523 |
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -37 311 | 1 137 977 | -3,17 | 32,06 | -1 196 191 | 36 483 543 |
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -41 896 | 41 896 | -50,00 | ||||
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 896 | 1 175 288 | 3,70 | ||||
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -2 800 | 1 133 392 | -0,25 | 30,94 | -86 632 | 35 067 148 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -11 200 | 1 136 192 | -0,98 | 31,39 | -351 568 | 35 665 067 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -6 428 | 1 147 392 | -0,56 | 30,94 | -198 882 | 35 500 308 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -27 913 | 1 153 820 | -2,36 | 31,39 | -876 189 | 36 218 410 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -34 341 | 0 | -100,00 | ||||
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 341 | 1 181 733 | 2,99 | ||||
| 2020-12-21 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -34 000 | 0 | -100,00 | ||||
| 2020-12-21 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 000 | 1 147 392 | 3,05 | 2,74 | 93 160 | 3 143 854 | |
| 2020-11-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -19 131 | 1 113 392 | -1,69 | 26,91 | -514 815 | 29 961 379 |
| 2020-11-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -30 869 | 1 132 523 | -2,65 | 25,99 | -802 285 | 29 434 273 |
| 2020-11-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -50 000 | 1 163 392 | -4,12 | 25,00 | -1 250 000 | 29 084 800 |
| 2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 83 542 | 83 542 | |||||
| 2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 66 886 | 66 886 | |||||
| 2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
J - Other | -9 323 | 1 213 392 | -0,76 | 23,61 | -220 116 | 28 648 185 | |
| 2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 18 008 | 1 222 715 | 1,49 | ||||
| 2020-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -41 895 | 1 204 707 | -3,36 | 26,16 | -1 095 973 | 31 515 135 |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -16 000 | 34 000 | -32,00 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -44 000 | 0 | -100,00 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -41 895 | 83 792 | -33,33 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 000 | 1 246 602 | 1,30 | 2,74 | 43 840 | 3 415 689 | |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 44 000 | 1 230 602 | 3,71 | 2,74 | 120 560 | 3 371 849 | |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 895 | 1 186 602 | 3,66 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -37 659 | 1 144 707 | -3,19 | 30,39 | -1 144 457 | 34 787 646 |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -7 939 | 1 182 366 | -0,67 | 29,78 | -236 423 | 35 210 859 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -34 340 | 34 341 | -50,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -11 258 | 0 | -100,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 340 | 1 190 305 | 2,97 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 258 | 1 155 965 | 0,98 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -56 | 1 144 707 | 0,00 | 34,30 | -1 921 | 39 263 450 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -3 000 | 1 144 763 | -0,26 | 33,25 | -99 750 | 38 063 370 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -10 722 | 1 147 763 | -0,93 | 32,43 | -347 714 | 37 221 954 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -3 700 | 1 158 485 | -0,32 | 31,85 | -117 845 | 36 897 747 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -6 000 | 44 000 | -12,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 000 | 1 162 185 | 0,52 | 2,74 | 16 440 | 3 184 387 | |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 17 478 | 1 156 185 | 1,53 | ||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 125 687 | 125 687 | |||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 172 697 | 172 697 | |||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -6 604 | 1 138 707 | -0,58 | 12,43 | -82 088 | 14 154 128 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -6 604 | 0 | -100,00 | ||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -7 539 | 1 145 311 | -0,65 | 11,82 | -89 111 | 13 537 576 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -38 059 | 1 152 850 | -3,20 | 11,38 | -433 111 | 13 119 433 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 604 | 1 190 909 | 0,56 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -34 340 | 68 681 | -33,33 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -11 258 | 11 258 | -50,00 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 340 | 1 184 305 | 2,99 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 258 | 1 149 965 | 0,99 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -17 478 | 1 138 707 | -1,51 | 11,09 | -193 831 | 12 628 261 |
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 17 478 | 1 156 185 | 1,53 | ||||
| 2018-12-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -50 000 | 0 | -100,00 | ||||
| 2018-12-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 1 138 707 | 4,59 | 1,50 | 75 000 | 1 708 060 | |
| 2018-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -6 604 | 1 088 707 | -0,60 | 17,48 | -115 438 | 19 030 598 |
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -11 257 | 1 095 311 | -1,02 | 17,08 | -192 270 | 18 707 912 |
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -6 604 | 6 604 | -50,00 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 604 | 1 106 568 | 0,60 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 103 021 | 103 021 | |||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 138 473 | 138 473 | |||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | -11 257 | 22 516 | -33,33 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 257 | 1 099 964 | 1,03 | ||||
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | -18 750 | 0 | -100,00 | |||
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -18 750 | 1 088 707 | -1,69 | 15,75 | -295 312 | 17 147 135 |
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 18 750 | 1 107 457 | 1,72 | 1,50 | 28 125 | 1 661 186 |
| 2017-01-09 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -4 081 | 1 088 707 | -0,37 | 16,55 | -67 541 | 18 018 101 |
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
M - Exercise | -6 603 | 13 208 | -33,33 | ||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 603 | 1 092 788 | 0,61 | ||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
A - Award | 33 773 | 33 773 | |||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 135 399 | 135 399 | |||||
| 2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 19 811 | 19 811 | |||||
| 2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 83 528 | 83 528 | |||||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | -18 750 | 18 750 | -50,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | -25 000 | 0 | -100,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | -25 000 | 0 | -100,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -1 800 | 1 086 185 | -0,17 | 55,08 | -99 144 | 59 827 070 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -19 654 | 1 087 985 | -1,77 | 54,24 | -1 066 033 | 59 012 306 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | -30 046 | 1 107 639 | -2,64 | 53,56 | -1 609 264 | 59 325 145 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 18 750 | 1 137 685 | 1,68 | 1,50 | 28 125 | 1 706 528 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 25 000 | 1 118 935 | 2,29 | 1,36 | 34 000 | 1 521 752 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 25 000 | 1 093 935 | 2,34 | 0,60 | 15 000 | 656 361 |
| 2015-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 228 380 | 228 380 | |||||
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | -35 000 | 1 068 935 | -3,17 | 14,75 | -516 250 | 15 766 791 | |
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | -50 000 | 0 | -100,00 | ||||
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 1 103 935 | 4,74 | 0,50 | 25 000 | 551 968 | |
| 2014-07-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 200 000 | 200 000 | |||||
| 2013-09-09 | 3 | NONE |
Intra-Cellular Therapies, Inc.
Common Stock |
1 053 935 |